eIF4E expression in tumors: its possible role in progression of malignancies

被引:285
作者
De Benedetti, A
Harris, AL
机构
[1] Louisiana State Univ, Med Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71130 USA
[2] Univ Oxford, John Radcliffe Hosp, Inst Mol Med, Oxford OX3 9DU, England
关键词
EIF4E oncogene; tumor vascularization; cancer progression; survival factor; histologic marker;
D O I
10.1016/S1357-2725(98)00132-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A central issue in the study of neoplastic transformation is to understand how proto-oncogene products deregulate normal processes of cell growth and differentiation; an intrinsic aspect of this is to probe the sequence of events leading to altered expression of proto-oncogenes. In the past few years, studies aimed at understanding the regulation and function of protein synthesis initiation factors, eIF4E initially, culminated in the unexpected finding that a moderate overexpression of this factor results in dramatic phenotypic changes, including rapid proliferation and malignant transformation. Conversely, the tumorigenic properties of cancer cells can be strongly inhibited by antisense-RNA against eIF4E, or overexpression of the inhibitory proteins: 4E-BPs. Furthermore, eIF4E is elevated in carcinomas of the breast, head and neck (HNSCC) and prostate, but not in typical benign lesions. This is a strong indication that elevated eIF4E expression may mark a critical transition in cancer progression. Establishing a greater protein synthesis output may be a necessary step for cancer cells in order to sustain their rapid proliferation. However, analysis of cells transformed by eIF4E revealed that the synthesis of only a few proteins was greatly enhanced, while synthesis of most was minimally increased. One possible explanation is that eIF4E causes these effects by specifically increasing the translational efficiency of several oncogene transcripts, leading to overexpression of their products. The feasibility of this hypothesis was confirmed experimentally with the identification of several important products that are specifically upregulated in eIF4E-overexpressing cells. These include: c-Myc, cyclin D1 and ODC, which control cycle progression and tumorigenesis; basic fibroblast growth factor (FGF-2) and vascular endothelial growth factor (VEGF), which are powerful promoters of cell growth and angiogenesis. A deeper understanding of the mRNAs that are strongly dependent on excess eIF4E/F for efficient translation will eventually result in fuller understanding of the fundamental role of translational control in different pathophysiological conditions, including malignancy. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:59 / 72
页数:14
相关论文
共 107 条
[91]  
SMITH MR, 1991, NEW BIOL, V3, P601
[92]   MULTIPLE RNAS EXPRESSED FROM THE INT-2 GENE IN MOUSE EMBRYONAL CARCINOMA CELL-LINES ENCODE A PROTEIN WITH HOMOLOGY TO FIBROBLAST GROWTH-FACTORS [J].
SMITH, R ;
PETERS, G ;
DICKSON, C .
EMBO JOURNAL, 1988, 7 (04) :1013-1022
[93]   The mRNA 5′ cap-binding protein eIF4E and control of cell growth [J].
Sonenberg, N ;
Gingras, AC .
CURRENT OPINION IN CELL BIOLOGY, 1998, 10 (02) :268-275
[94]  
Sonenberg Nahum, 1993, Gene Expression, V3, P317
[95]   Detection of eIF4E gene amplification in breast cancer by competitive PCR [J].
Sorrells, DL ;
Black, DR ;
Meschonat, C ;
Rhoads, R ;
De Benedetti, A ;
Gao, MX ;
Williams, BJ ;
Li, BDL .
ANNALS OF SURGICAL ONCOLOGY, 1998, 5 (03) :232-237
[96]   Translation of vascular endothelial growth factor mRNA by internal ribosome entry: Implications for translation under hypoxia [J].
Stein, I ;
Itin, A ;
Einat, P ;
Skaliter, R ;
Grossman, Z ;
Keshet, E .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (06) :3112-3119
[97]   C-Myc 5′ untranslated region contains an internal ribosome entry segment [J].
Stoneley, M ;
Paulin, FEM ;
Le Quesne, JPC ;
Chappell, SA ;
Willis, AE .
ONCOGENE, 1998, 16 (03) :423-428
[98]   CAP RECAP - THE INVOLVEMENT OF EIF-4F IN REGULATING GENE-EXPRESSION [J].
THACH, RE .
CELL, 1992, 68 (02) :177-180
[99]  
THEILLET C, 1989, ONCOGENE, V4, P915
[100]  
Trachsel H., 1991, TRANSLATION EUKARYOT